THE SIGNAL
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.
Sold by Vertex Pharmaceuticals in 50-milligram tablets as Journavx, suzetrigine is the first nonopioid painkiller to target pain-signaling pathways in the peripheral nervous system before those signals reach the brain, the FDA said.
The last painkiller OK’d by the FDA was Celebrex, a Cox‑2 inhibitor, according to CNN. That category of nonsteroidal, anti-inflammatory drug works by targeting the body’s production of a chemical that causes pain.
Suzetrigine is intended to tre …
COMMENT SECTION →